Theiler's Virus-Mediated Immunopathology in the CNS and Heart: Roles of Organ-Specific Cytokine and Lymphatic Responses
Theiler's murine encephalomyelitis virus (TMEV) induces different diseases in the central nervous system (CNS) and heart, depending on the mouse strains and time course, with cytokines playing key roles for viral clearance and immune-mediated pathology (immunopathology). In SJL/J mice, TMEV inf...
Saved in:
| Published in | Frontiers in immunology Vol. 9; p. 2870 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Media S.A
10.12.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Theiler's murine encephalomyelitis virus (TMEV) induces different diseases in the central nervous system (CNS) and heart, depending on the mouse strains and time course, with cytokines playing key roles for viral clearance and immune-mediated pathology (immunopathology). In SJL/J mice, TMEV infection causes chronic TMEV-induced demyelinating disease (TMEV-IDD) in the spinal cord about 1 month post-inoculation (p.i.). Unlike other immunopathology models, both pro- and anti-inflammatory cytokines can play dual roles in TMEV-IDD. Pro-inflammatory cytokines play beneficial roles in viral clearance while they are also detrimental in immune-mediated demyelination. Anti-inflammatory cytokines suppress not only protective anti-viral immune responses but also detrimental autoreactive immune responses. Conversely, in C3H mice, TMEV infection induces a non-CNS disease, myocarditis, with three distinctive phases: phase I, viral pathology with interferon and chemokine responses; phase II, immunopathology mediated by acquired immune responses; and phase III, cardiac fibrosis. Although the exact mechanism(s) by which a single virus, TMEV, induces these different diseases in different organs is unclear, our bioinformatics approaches, especially principal component analysis (PCA) of transcriptome data, allow us to identify the key factors contributing to organ-specific immunopathology. The PCA demonstrated that
infection of a cardiomyocyte cell line reproduced the transcriptome profile of phase I in TMEV-induced myocarditis; distinct interferon/chemokine-related responses were induced
in TMEV-infected cardiomyocytes, but not in infected neuronal cells. In addition, the PCA of the
CNS transcriptome data showed that decreased lymphatic marker expressions were weakly associated with inflammation in TMEV infection. Here, dysfunction of lymphatic vessels is shown to potentially contribute to immunopathology by delaying the clearance of cytokines and immune cells from the inflammatory site, although this can also confine the virus at these sites, preventing virus spread via lymphatic vessels. On the other hand, in the heart, dysfunction of lymphatics was associated with reduced lymphatic muscle contractility provoked by pro-inflammatory cytokines. Therefore, TMEV infection may induce different patterns of cytokine expressions as well as lymphatic vessel dysfunction by rather different mechanisms between the CNS and heart, which might explain observed patterns of organ-specific immunopathology. |
|---|---|
| AbstractList | Theiler's murine encephalomyelitis virus (TMEV) induces different diseases in the central nervous system (CNS) and heart, depending on the mouse strains and time course, with cytokines playing key roles for viral clearance and immune-mediated pathology (immunopathology). In SJL/J mice, TMEV infection causes chronic TMEV-induced demyelinating disease (TMEV-IDD) in the spinal cord about 1 month post-inoculation (p.i.). Unlike other immunopathology models, both pro- and anti-inflammatory cytokines can play dual roles in TMEV-IDD. Pro-inflammatory cytokines play beneficial roles in viral clearance while they are also detrimental in immune-mediated demyelination. Anti-inflammatory cytokines suppress not only protective anti-viral immune responses but also detrimental autoreactive immune responses. Conversely, in C3H mice, TMEV infection induces a non-CNS disease, myocarditis, with three distinctive phases: phase I, viral pathology with interferon and chemokine responses; phase II, immunopathology mediated by acquired immune responses; and phase III, cardiac fibrosis. Although the exact mechanism(s) by which a single virus, TMEV, induces these different diseases in different organs is unclear, our bioinformatics approaches, especially principal component analysis (PCA) of transcriptome data, allow us to identify the key factors contributing to organ-specific immunopathology. The PCA demonstrated that in vitro infection of a cardiomyocyte cell line reproduced the transcriptome profile of phase I in TMEV-induced myocarditis; distinct interferon/chemokine-related responses were induced in vitro in TMEV-infected cardiomyocytes, but not in infected neuronal cells. In addition, the PCA of the in vivo CNS transcriptome data showed that decreased lymphatic marker expressions were weakly associated with inflammation in TMEV infection. Here, dysfunction of lymphatic vessels is shown to potentially contribute to immunopathology by delaying the clearance of cytokines and immune cells from the inflammatory site, although this can also confine the virus at these sites, preventing virus spread via lymphatic vessels. On the other hand, in the heart, dysfunction of lymphatics was associated with reduced lymphatic muscle contractility provoked by pro-inflammatory cytokines. Therefore, TMEV infection may induce different patterns of cytokine expressions as well as lymphatic vessel dysfunction by rather different mechanisms between the CNS and heart, which might explain observed patterns of organ-specific immunopathology. Theiler's murine encephalomyelitis virus (TMEV) induces different diseases in the central nervous system (CNS) and heart, depending on the mouse strains and time course, with cytokines playing key roles for viral clearance and immune-mediated pathology (immunopathology). In SJL/J mice, TMEV infection causes chronic TMEV-induced demyelinating disease (TMEV-IDD) in the spinal cord about 1 month post-inoculation (p.i.). Unlike other immunopathology models, both pro- and anti-inflammatory cytokines can play dual roles in TMEV-IDD. Pro-inflammatory cytokines play beneficial roles in viral clearance while they are also detrimental in immune-mediated demyelination. Anti-inflammatory cytokines suppress not only protective anti-viral immune responses but also detrimental autoreactive immune responses. Conversely, in C3H mice, TMEV infection induces a non-CNS disease, myocarditis, with three distinctive phases: phase I, viral pathology with interferon and chemokine responses; phase II, immunopathology mediated by acquired immune responses; and phase III, cardiac fibrosis. Although the exact mechanism(s) by which a single virus, TMEV, induces these different diseases in different organs is unclear, our bioinformatics approaches, especially principal component analysis (PCA) of transcriptome data, allow us to identify the key factors contributing to organ-specific immunopathology. The PCA demonstrated that infection of a cardiomyocyte cell line reproduced the transcriptome profile of phase I in TMEV-induced myocarditis; distinct interferon/chemokine-related responses were induced in TMEV-infected cardiomyocytes, but not in infected neuronal cells. In addition, the PCA of the CNS transcriptome data showed that decreased lymphatic marker expressions were weakly associated with inflammation in TMEV infection. Here, dysfunction of lymphatic vessels is shown to potentially contribute to immunopathology by delaying the clearance of cytokines and immune cells from the inflammatory site, although this can also confine the virus at these sites, preventing virus spread via lymphatic vessels. On the other hand, in the heart, dysfunction of lymphatics was associated with reduced lymphatic muscle contractility provoked by pro-inflammatory cytokines. Therefore, TMEV infection may induce different patterns of cytokine expressions as well as lymphatic vessel dysfunction by rather different mechanisms between the CNS and heart, which might explain observed patterns of organ-specific immunopathology. Theiler's murine encephalomyelitis virus (TMEV) induces different diseases in the central nervous system (CNS) and heart, depending on the mouse strains and time course, with cytokines playing key roles for viral clearance and immune-mediated pathology (immunopathology). In SJL/J mice, TMEV infection causes chronic TMEV-induced demyelinating disease (TMEV-IDD) in the spinal cord about 1 month post-inoculation (p.i.). Unlike other immunopathology models, both pro- and anti-inflammatory cytokines can play dual roles in TMEV-IDD. Pro-inflammatory cytokines play beneficial roles in viral clearance while they are also detrimental in immune-mediated demyelination. Anti-inflammatory cytokines suppress not only protective anti-viral immune responses but also detrimental autoreactive immune responses. Conversely, in C3H mice, TMEV infection induces a non-CNS disease, myocarditis, with three distinctive phases: phase I, viral pathology with interferon and chemokine responses; phase II, immunopathology mediated by acquired immune responses; and phase III, cardiac fibrosis. Although the exact mechanism(s) by which a single virus, TMEV, induces these different diseases in different organs is unclear, our bioinformatics approaches, especially principal component analysis (PCA) of transcriptome data, allow us to identify the key factors contributing to organ-specific immunopathology. The PCA demonstrated that in vitro infection of a cardiomyocyte cell line reproduced the transcriptome profile of phase I in TMEV-induced myocarditis; distinct interferon/chemokine-related responses were induced in vitro in TMEV-infected cardiomyocytes, but not in infected neuronal cells. In addition, the PCA of the in vivo CNS transcriptome data showed that decreased lymphatic marker expressions were weakly associated with inflammation in TMEV infection. Here, dysfunction of lymphatic vessels is shown to potentially contribute to immunopathology by delaying the clearance of cytokines and immune cells from the inflammatory site, although this can also confine the virus at these sites, preventing virus spread via lymphatic vessels. On the other hand, in the heart, dysfunction of lymphatics was associated with reduced lymphatic muscle contractility provoked by pro-inflammatory cytokines. Therefore, TMEV infection may induce different patterns of cytokine expressions as well as lymphatic vessel dysfunction by rather different mechanisms between the CNS and heart, which might explain observed patterns of organ-specific immunopathology. Theiler's murine encephalomyelitis virus (TMEV) induces different diseases in the central nervous system (CNS) and heart, depending on the mouse strains and time course, with cytokines playing key roles for viral clearance and immune-mediated pathology (immunopathology). In SJL/J mice, TMEV infection causes chronic TMEV-induced demyelinating disease (TMEV-IDD) in the spinal cord about 1 month post-inoculation (p.i.). Unlike other immunopathology models, both pro- and anti-inflammatory cytokines can play dual roles in TMEV-IDD. Pro-inflammatory cytokines play beneficial roles in viral clearance while they are also detrimental in immune-mediated demyelination. Anti-inflammatory cytokines suppress not only protective anti-viral immune responses but also detrimental autoreactive immune responses. Conversely, in C3H mice, TMEV infection induces a non-CNS disease, myocarditis, with three distinctive phases: phase I, viral pathology with interferon and chemokine responses; phase II, immunopathology mediated by acquired immune responses; and phase III, cardiac fibrosis. Although the exact mechanism(s) by which a single virus, TMEV, induces these different diseases in different organs is unclear, our bioinformatics approaches, especially principal component analysis (PCA) of transcriptome data, allow us to identify the key factors contributing to organ-specific immunopathology. The PCA demonstrated that in vitro infection of a cardiomyocyte cell line reproduced the transcriptome profile of phase I in TMEV-induced myocarditis; distinct interferon/chemokine-related responses were induced in vitro in TMEV-infected cardiomyocytes, but not in infected neuronal cells. In addition, the PCA of the in vivo CNS transcriptome data showed that decreased lymphatic marker expressions were weakly associated with inflammation in TMEV infection. Here, dysfunction of lymphatic vessels is shown to potentially contribute to immunopathology by delaying the clearance of cytokines and immune cells from the inflammatory site, although this can also confine the virus at these sites, preventing virus spread via lymphatic vessels. On the other hand, in the heart, dysfunction of lymphatics was associated with reduced lymphatic muscle contractility provoked by pro-inflammatory cytokines. Therefore, TMEV infection may induce different patterns of cytokine expressions as well as lymphatic vessel dysfunction by rather different mechanisms between the CNS and heart, which might explain observed patterns of organ-specific immunopathology.Theiler's murine encephalomyelitis virus (TMEV) induces different diseases in the central nervous system (CNS) and heart, depending on the mouse strains and time course, with cytokines playing key roles for viral clearance and immune-mediated pathology (immunopathology). In SJL/J mice, TMEV infection causes chronic TMEV-induced demyelinating disease (TMEV-IDD) in the spinal cord about 1 month post-inoculation (p.i.). Unlike other immunopathology models, both pro- and anti-inflammatory cytokines can play dual roles in TMEV-IDD. Pro-inflammatory cytokines play beneficial roles in viral clearance while they are also detrimental in immune-mediated demyelination. Anti-inflammatory cytokines suppress not only protective anti-viral immune responses but also detrimental autoreactive immune responses. Conversely, in C3H mice, TMEV infection induces a non-CNS disease, myocarditis, with three distinctive phases: phase I, viral pathology with interferon and chemokine responses; phase II, immunopathology mediated by acquired immune responses; and phase III, cardiac fibrosis. Although the exact mechanism(s) by which a single virus, TMEV, induces these different diseases in different organs is unclear, our bioinformatics approaches, especially principal component analysis (PCA) of transcriptome data, allow us to identify the key factors contributing to organ-specific immunopathology. The PCA demonstrated that in vitro infection of a cardiomyocyte cell line reproduced the transcriptome profile of phase I in TMEV-induced myocarditis; distinct interferon/chemokine-related responses were induced in vitro in TMEV-infected cardiomyocytes, but not in infected neuronal cells. In addition, the PCA of the in vivo CNS transcriptome data showed that decreased lymphatic marker expressions were weakly associated with inflammation in TMEV infection. Here, dysfunction of lymphatic vessels is shown to potentially contribute to immunopathology by delaying the clearance of cytokines and immune cells from the inflammatory site, although this can also confine the virus at these sites, preventing virus spread via lymphatic vessels. On the other hand, in the heart, dysfunction of lymphatics was associated with reduced lymphatic muscle contractility provoked by pro-inflammatory cytokines. Therefore, TMEV infection may induce different patterns of cytokine expressions as well as lymphatic vessel dysfunction by rather different mechanisms between the CNS and heart, which might explain observed patterns of organ-specific immunopathology. |
| Author | Trutschl, Marjan Sato, Fumitaka Minagar, Alireza Alexander, J. Steven Martinez, Nicholas E. Cvek, Urska Tsunoda, Ikuo Kawai, Eiichiro Al-Kofahi, Mahmoud Yun, J. Winny Omura, Seiichi |
| AuthorAffiliation | 2 Department of Microbiology and Immunology, Center for Molecular and Tumor Virology, Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center-Shreveport , Shreveport, LA , United States 3 Department of Neurology, Louisiana State University Health Sciences Center-Shreveport , Shreveport, LA , United States 4 Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center-Shreveport , Shreveport, LA , United States 5 Department of Computer Science, Louisiana State University Shreveport , Shreveport, LA , United States 1 Department of Microbiology, Kindai University Faculty of Medicine , Osaka , Japan |
| AuthorAffiliation_xml | – name: 1 Department of Microbiology, Kindai University Faculty of Medicine , Osaka , Japan – name: 4 Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center-Shreveport , Shreveport, LA , United States – name: 2 Department of Microbiology and Immunology, Center for Molecular and Tumor Virology, Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center-Shreveport , Shreveport, LA , United States – name: 5 Department of Computer Science, Louisiana State University Shreveport , Shreveport, LA , United States – name: 3 Department of Neurology, Louisiana State University Health Sciences Center-Shreveport , Shreveport, LA , United States |
| Author_xml | – sequence: 1 givenname: Seiichi surname: Omura fullname: Omura, Seiichi – sequence: 2 givenname: Eiichiro surname: Kawai fullname: Kawai, Eiichiro – sequence: 3 givenname: Fumitaka surname: Sato fullname: Sato, Fumitaka – sequence: 4 givenname: Nicholas E. surname: Martinez fullname: Martinez, Nicholas E. – sequence: 5 givenname: Alireza surname: Minagar fullname: Minagar, Alireza – sequence: 6 givenname: Mahmoud surname: Al-Kofahi fullname: Al-Kofahi, Mahmoud – sequence: 7 givenname: J. Winny surname: Yun fullname: Yun, J. Winny – sequence: 8 givenname: Urska surname: Cvek fullname: Cvek, Urska – sequence: 9 givenname: Marjan surname: Trutschl fullname: Trutschl, Marjan – sequence: 10 givenname: J. Steven surname: Alexander fullname: Alexander, J. Steven – sequence: 11 givenname: Ikuo surname: Tsunoda fullname: Tsunoda, Ikuo |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30619258$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1ks9vFCEUxyemxv6wd0-Gm15mHWBgwIOJ2Vi7yWqTtnolLPPYpc7ACDOa_e9ld2vTmsgByHvf93mQ9z0tjnzwUBSvcDWjVMh31vX9NCMVFrOKiKZ6VpxgzuuSElIfPbofF-cp3VV51ZJSyl4Ux7TiWBImTorftxtwHcQ3CX13cUrlF2idHqFFi0z3YdDjJnRhvUXOo3EDaP71BmnfokvQcXyPrkMHCQWLruJa-_JmAOOsM2i-HcMP52GvXW77YaPHHL6GNASfIL0snlvdJTi_P8-KbxefbueX5fLq82L-cVkaRsRYQiNZ2-qqZlIAtYyZhkvZ1q0RomEraAwWQkBO5o2A5UZwLiRYTbHV1tKzYnHgtkHfqSG6XsetCtqpfSDEtcr_cKYDxQimYAWXpoWa0ZXGgBtO60azRtMVZNaHA2uYVj20BvwYdfcE-jTj3Uatwy_FiWQ1lxnw9h4Qw88J0qh6lwx0nfYQpqQI5qyq88hIlr5-3Ouhyd_JZUF1EJgYUopgHyS4Ujt_qL0_1M4fau-PXML_KTFuzGMJu9e67v-FfwAPf8I_ |
| CitedBy_id | crossref_primary_10_3390_ijms20020448 crossref_primary_10_1089_lrb_2019_29063_fb crossref_primary_10_3390_cimb45020094 crossref_primary_10_3390_ijms24021581 crossref_primary_10_3390_ijms251910656 crossref_primary_10_3390_ijms22168486 crossref_primary_10_3389_fneur_2023_1216477 crossref_primary_10_3389_fimmu_2020_01138 crossref_primary_10_3390_ijms22041914 crossref_primary_10_3389_fnmol_2022_1019799 crossref_primary_10_1007_s00705_021_04968_5 crossref_primary_10_1111_imr_13124 crossref_primary_10_3390_ijms24043514 crossref_primary_10_1007_s40588_020_00138_4 crossref_primary_10_1111_bpa_12994 |
| Cites_doi | 10.1038/srep02053 10.1016/B978-0-12-811709-5.00003-X 10.1016/S0168-1702(01)00256-8 10.1111/j.1471-4159.2007.05008.x 10.1016/S0735-1097(14)60971-2 10.1056/NEJMra0800028 10.1126/science.80.2066.122-a 10.1186/s12974-017-0868-8 10.1111/bpa.12119 10.1016/j.cell.2012.07.021 10.1128/mBio.01354-17 10.2174/1381612822666161214153108 10.1016/j.celrep.2017.09.006 10.1016/S0165-5728(99)00251-9 10.1007/0-387-25518-4_29 10.1021/pr700734f 10.1016/j.biopha.2018.08.004 10.1093/intimm/9.12.1837 10.1016/j.yexmp.2018.03.002 10.1111/cen3.12400 10.1016/j.jacc.2011.09.074 10.1128/JVI.70.12.8926-8933.1996 10.1007/s11481-017-9775-0 10.1016/j.jconrel.2013.04.027 10.1007/s11936-012-0204-7 10.1038/sj.tpj.6500412 10.1186/s13148-016-0221-6 10.1096/fj.201700746R 10.1007/s11481-018-9778-5 10.1007/s004010050472 10.1006/viro.1996.8382 10.1128/9781555819521 10.1172/JCI71607 10.1084/jem.65.5.705 10.1084/jem.96.6.517 10.1038/nrd4608 10.1097/MIB.0000000000000731 10.1111/j.1750-3639.2006.00042.x 10.1073/pnas.95.6.2979 10.1186/1742-2094-10-125 10.1016/j.pathophys.2010.04.011 10.1016/B978-0-12-800763-1.00004-X 10.1016/j.molmed.2012.05.005 10.1016/j.arcmed.2014.11.013 10.2217/fvl.12.44 10.1084/jem.20091385 10.1097/BOR.0b013e328353372d 10.1093/intimm/dxw045 10.1080/13550280802400684 10.1016/j.jneuroim.2014.11.003 10.1128/JVI.76.24.12834-12844.2002 10.2217/17460794.3.6.579 10.1016/S0092-8674(01)00638-9 10.1016/j.cellimm.2014.10.004 10.1142/S0219720012310038 10.1161/CIRCGENETICS.114.000505 10.1179/016164106X98080 10.4049/jimmunol.135.2.1408 10.1111/cen3.12405 10.1128/JVI.01501-15 10.1097/00005072-199712000-00005 10.1016/j.jneuroim.2007.07.026 10.1038/nature14432 10.1161/hc3401.095198 |
| ContentType | Journal Article |
| Copyright | Copyright © 2018 Omura, Kawai, Sato, Martinez, Minagar, Al-Kofahi, Yun, Cvek, Trutschl, Alexander and Tsunoda. 2018 Omura, Kawai, Sato, Martinez, Minagar, Al-Kofahi, Yun, Cvek, Trutschl, Alexander and Tsunoda |
| Copyright_xml | – notice: Copyright © 2018 Omura, Kawai, Sato, Martinez, Minagar, Al-Kofahi, Yun, Cvek, Trutschl, Alexander and Tsunoda. 2018 Omura, Kawai, Sato, Martinez, Minagar, Al-Kofahi, Yun, Cvek, Trutschl, Alexander and Tsunoda |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.3389/fimmu.2018.02870 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1664-3224 |
| ExternalDocumentID | oai_doaj_org_article_5213ef869cde453ba1e176347a57a3be PMC6295469 30619258 10_3389_fimmu_2018_02870 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: P20 GM103433 – fundername: Novartis Pharma – fundername: Japan Society for the Promotion of Science – fundername: National Institute of General Medical Sciences |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM CGR CUY CVF ECM EIF IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c528t-e795dda04598e3f55c7699d4dc8875be7c1888e98e8e92ef6c86689efa31faff3 |
| IEDL.DBID | M48 |
| ISSN | 1664-3224 |
| IngestDate | Wed Aug 27 01:24:24 EDT 2025 Thu Aug 21 14:29:33 EDT 2025 Fri Jul 11 10:05:17 EDT 2025 Thu Apr 03 07:10:07 EDT 2025 Tue Jul 01 01:35:39 EDT 2025 Thu Apr 24 23:06:22 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Picornaviridae infection blood-brain barrier animal models adhesion molecules unsupervised analysis GLYCAM1 computational analysis LYVE1 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c528t-e795dda04598e3f55c7699d4dc8875be7c1888e98e8e92ef6c86689efa31faff3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology Edited by: Michael H. Lehmann, Ludwig Maximilian University of Munich, Germany Reviewed by: Jun-ichi Kira, Kyushu University, Japan; Andreas Beineke, University of Veterinary Medicine Hannover, Germany |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2018.02870 |
| PMID | 30619258 |
| PQID | 2165042242 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_5213ef869cde453ba1e176347a57a3be pubmedcentral_primary_oai_pubmedcentral_nih_gov_6295469 proquest_miscellaneous_2165042242 pubmed_primary_30619258 crossref_primary_10_3389_fimmu_2018_02870 crossref_citationtrail_10_3389_fimmu_2018_02870 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-12-10 |
| PublicationDateYYYYMMDD | 2018-12-10 |
| PublicationDate_xml | – month: 12 year: 2018 text: 2018-12-10 day: 10 |
| PublicationDecade | 2010 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in immunology |
| PublicationTitleAlternate | Front Immunol |
| PublicationYear | 2018 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Lipton (B11) 2001; 76 Becker (B54) 2016; 22 Tsunoda (B43) 1997; 228 Omura (B33) 2014; 7 Inoue (B64) 1997; 9 Corsten (B30) 2012; 18 Tsunoda (B63) 2007; 17 Tsunoda (B47) 2009; 15 Kim (B51) 2014; 124 Cooper (B25) 2009; 360 Martinez (B28) 2012; 7 Tsunoda (B13) 1997; 56 Al-Kofahi (B53) 2017; 8 Oberg (B45) 2008; 7 Theil (B20) 2000; 104 Kawai (B10) 2015; 278 Shauer (B32) 2013; 15 Fairweather (B27) 2012; 24 Martinez (B24) 2014; 24 Tsunoda (B69) 2017; 8 Tsunoda (B22) 2005 Dave (B57) 2018; 13 Clatch (B17) 1985; 135 Theiler (B2) 1937; 65 Ortiz (B60) 2014; 45 Bjelobaba (B6) 2017; 23 Liu (B29) 2001; 104 Al-Kofahi (B55) 2018; 107 Proulx (B35) 2013; 172 Chen (B44) 2007; 7 Flint (B14) 2015 Claycomb (B41) 1998; 95 Starnawska (B49) 2016; 8 Religa (B52) 2013; 3 McCright (B15) 1997; 3 Niwa (B48) 2002; 108 Loo (B38) 2017; 20 Tsunoda (B3) 1999 Ohtsuki (B67) 2008; 104 Johnson (B56) 1998 Williams (B65) 2017; 14 Daniels (B4) 1952; 96 Wuest (B50) 2010; 207 Sato (B7) 2018 Hirano (B66) 2016; 28 Bleau (B68) 2015; 89 Tsunoda (B19) 1996; 91 Shafiei (B42) 2014; 63 Dave (B59) 2017; 13 Williams (B12) 2018; 9 Kindermann (B31) 2012; 59 Sato (B5) 2011; 18 Sato (B23) 2016 Chaitanya (B39) 2013; 10 Guglin (B26) 2012 Sato (B9) 2014; 292 Omura (B61) 2018; 23 Li (B46) 2012 Tsunoda (B21) 2007; 190 Tsunoda (B18) 2002; 76 Louveau (B58) 2015; 523 Theiler (B1) 1934; 80 Tsunoda (B16) 2008; 3 Minagar (B62) 2006; 28 Trevaskis (B36) 2015; 14 Tang (B34) 2018; 104 Gómez (B8) 1996; 70 Kastenmüller (B37) 2012; 150 Smith (B40) 2018; 32 |
| References_xml | – volume: 3 start-page: 2053 year: 2013 ident: B52 article-title: VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival publication-title: Sci Rep doi: 10.1038/srep02053 – start-page: 37 volume-title: Neuroinflammation. year: 2018 ident: B7 article-title: Animal models of multiple sclerosis doi: 10.1016/B978-0-12-811709-5.00003-X – volume: 76 start-page: 79 year: 2001 ident: B11 article-title: Serological evidence that Mus musculus is the natural host of Theiler's murine encephalomyelitis virus publication-title: Virus Res doi: 10.1016/S0168-1702(01)00256-8 – volume: 104 start-page: 147 year: 2008 ident: B67 article-title: mRNA expression levels of tight junction protein genes in mouse brain capillary endothelial cells highly purified by magnetic cell sorting publication-title: J Neurochem doi: 10.1111/j.1471-4159.2007.05008.x – volume: 63 start-page: A971 year: 2014 ident: B42 article-title: Computational multivariate analyses for phase-specific biomarker identification in novel in vivo and in vitro viral myocarditis models induced by cardiovirus publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(14)60971-2 – volume: 360 start-page: 1526 year: 2009 ident: B25 article-title: Myocarditis publication-title: N Engl J Med doi: 10.1056/NEJMra0800028 – volume: 80 start-page: 122 year: 1934 ident: B1 article-title: Spontaneous encephalomyelitis of mice–a new virus disease publication-title: Science doi: 10.1126/science.80.2066.122-a – volume: 14 start-page: 93 year: 2017 ident: B65 article-title: GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to rediation-based protection in glaucoma publication-title: J Neuroinflammation doi: 10.1186/s12974-017-0868-8 – volume: 24 start-page: 436 year: 2014 ident: B24 article-title: Protective and detrimental roles for regulatory T cells in a viral model for multiple sclerosis publication-title: Brain Pathol doi: 10.1111/bpa.12119 – volume: 150 start-page: 1235 year: 2012 ident: B37 article-title: A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread publication-title: Cell doi: 10.1016/j.cell.2012.07.021 – volume: 9 start-page: e01354 year: 2018 ident: B12 article-title: Viral diversity of house mice in New York City publication-title: MBio doi: 10.1128/mBio.01354-17 – volume: 23 start-page: 693 year: 2017 ident: B6 article-title: Multiple sclerosis and neuroinflammation: the overview of current and prospective therapies publication-title: Curr Pharm Des doi: 10.2174/1381612822666161214153108 – volume: 20 start-page: 3176 year: 2017 ident: B38 article-title: Lymphatic vessels balance viral dissemination and immune activation following cutaneous viral infection publication-title: Cell Rep doi: 10.1016/j.celrep.2017.09.006 – volume: 104 start-page: 22 year: 2000 ident: B20 article-title: Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections publication-title: J Neuroimmunol doi: 10.1016/S0165-5728(99)00251-9 – start-page: 593 volume-title: Experimental Models of Multiple Sclerosis. year: 2005 ident: B22 article-title: TMEV and neuroantigens: Myelin genes and proteins, molecular mimicry, epitope spreading and autoantibody-mediated remyelination doi: 10.1007/0-387-25518-4_29 – volume: 23 start-page: 114 year: 2018 ident: B61 article-title: Computational analyses associate the CNS lymphatic molecules with disease progression of a viral model for multiple sclerosis publication-title: Neuroinfection – volume: 7 start-page: 225 year: 2008 ident: B45 article-title: Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA publication-title: J Proteome Res doi: 10.1021/pr700734f – volume: 107 start-page: 1591 year: 2018 ident: B55 article-title: IL-1β reduces cardiac lymphatic muscle contraction via COX-2 and PGE2 Induction: Potential role in myocarditis publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2018.08.004 – volume: 9 start-page: 1837 year: 1997 ident: B64 article-title: Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus-induced demyelinating disease publication-title: Int Immunol doi: 10.1093/intimm/9.12.1837 – volume: 104 start-page: 140 year: 2018 ident: B34 article-title: Role of gene polymorphisms/haplotypes and serum levels of interleukin-17A in susceptibility to viral myocarditis publication-title: Exp Mol Pathol doi: 10.1016/j.yexmp.2018.03.002 – volume: 8 start-page: 4038 year: 2017 ident: B53 article-title: Anatomy and roles of lymphatics in inflammatory diseases publication-title: Clin Exp Neuroimmunol doi: 10.1111/cen3.12400 – volume: 59 start-page: 779 year: 2012 ident: B31 article-title: Update on myocarditis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.09.074 – volume: 70 start-page: 8926 year: 1996 ident: B8 article-title: Theiler's murine encephalomyelitis virus-induced cardiac and skeletal muscle disease publication-title: J Virol doi: 10.1128/JVI.70.12.8926-8933.1996 – volume: 13 start-page: 204 year: 2017 ident: B59 article-title: FDC:TFH interactions within cervical lymph nodes of SIV-infected rhesus macaques publication-title: J Neuroimmune Pharmacol doi: 10.1007/s11481-017-9775-0 – volume: 172 start-page: 550 year: 2013 ident: B35 article-title: Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery publication-title: J Control Release doi: 10.1016/j.jconrel.2013.04.027 – year: 2012 ident: B26 article-title: Myocarditis: diagnosis and treatment publication-title: Curr Treat Options Cardiovasc Med doi: 10.1007/s11936-012-0204-7 – volume: 7 start-page: 212 year: 2007 ident: B44 article-title: Selection of differentially expressed genes in microarray data analysis publication-title: Pharmacogenomics J doi: 10.1038/sj.tpj.6500412 – volume: 8 start-page: 52 year: 2016 ident: B49 article-title: Hypomethylation of FAM63B in bipolar disorder patients publication-title: Clin Epigenet. doi: 10.1186/s13148-016-0221-6 – volume: 32 start-page: 2381 year: 2018 ident: B40 article-title: Metallothionein I as a direct link between therapeutic hematopoietic stem/progenitor cells and cerebral protection in stroke publication-title: FASEB J doi: 10.1096/fj.201700746R – volume: 13 start-page: 123 year: 2018 ident: B57 article-title: Functional meningeal lymphatics and cerebrospinal fluid outflow publication-title: J Neuroimmune Pharmacol doi: 10.1007/s11481-018-9778-5 – volume: 91 start-page: 595 year: 1996 ident: B19 article-title: A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus publication-title: Acta Neuropathol doi: 10.1007/s004010050472 – volume: 228 start-page: 388 year: 1997 ident: B43 article-title: Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus publication-title: Virology doi: 10.1006/viro.1996.8382 – start-page: 24 volume-title: Principles of Virology. year: 2015 ident: B14 article-title: Barriers to infection doi: 10.1128/9781555819521 – volume: 124 start-page: 936 year: 2014 ident: B51 article-title: Inflammation-associated lymphangiogenesis: a double-edged sword? publication-title: J Clin Invest doi: 10.1172/JCI71607 – volume: 65 start-page: 705 year: 1937 ident: B2 article-title: Spontaneous encephalomyelitis of mice, a new virus disease publication-title: J Exp Med doi: 10.1084/jem.65.5.705 – volume: 96 start-page: 517 year: 1952 ident: B4 article-title: Observations on encephalomyelitis of mice (DA strain) publication-title: J Exp Med doi: 10.1084/jem.96.6.517 – volume: 14 start-page: 781 year: 2015 ident: B36 article-title: From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity publication-title: Nat Rev Drug Discov doi: 10.1038/nrd4608 – volume: 22 start-page: 1326 year: 2016 ident: B54 article-title: A Critical Role for monocytes/macrophages during intestinal inflammation-associated lymphangiogenesis publication-title: Inflamm Bowel Dis doi: 10.1097/MIB.0000000000000731 – volume: 17 start-page: 45 year: 2007 ident: B63 article-title: Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade publication-title: Brain Pathol doi: 10.1111/j.1750-3639.2006.00042.x – volume: 95 start-page: 2979 year: 1998 ident: B41 article-title: HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.95.6.2979 – volume: 10 start-page: 125 year: 2013 ident: B39 article-title: Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature publication-title: J Neuroinflammation doi: 10.1186/1742-2094-10-125 – volume: 18 start-page: 31 year: 2011 ident: B5 article-title: Theiler's virus infection: pathophysiology of demyelination and neurodegeneration publication-title: Pathophysiology doi: 10.1016/j.pathophys.2010.04.011 – start-page: 41 volume-title: Multiple Sclerosis: A Mechanistic View. year: 2016 ident: B23 article-title: Role of CD4+ T lymphocytes in pathophysiology of multiple sclerosis doi: 10.1016/B978-0-12-800763-1.00004-X – volume: 18 start-page: 426 year: 2012 ident: B30 article-title: Inflammation in viral myocarditis: friend or foe? publication-title: Trends Mol Med doi: 10.1016/j.molmed.2012.05.005 – volume: 45 start-page: 687 year: 2014 ident: B60 article-title: Role of the blood-brain barrier in multiple sclerosis publication-title: Arch Med Res doi: 10.1016/j.arcmed.2014.11.013 – volume: 7 start-page: 593 year: 2012 ident: B28 article-title: Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis publication-title: Future Virol doi: 10.2217/fvl.12.44 – volume: 207 start-page: 101 year: 2010 ident: B50 article-title: VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis publication-title: J Exp Med doi: 10.1084/jem.20091385 – volume: 24 start-page: 401 year: 2012 ident: B27 article-title: Update on coxsackievirus B3 myocarditis publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0b013e328353372d – volume: 28 start-page: 575 year: 2016 ident: B66 article-title: The role of α4 integrin in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: an infectious animal model for multiple sclerosis (MS) publication-title: Int Immunol doi: 10.1093/intimm/dxw045 – volume: 15 start-page: 90 year: 2009 ident: B47 article-title: Contrasting roles for Vα14+ natural killer T cells in a viral model for multiple sclerosis publication-title: J Neurovirol doi: 10.1080/13550280802400684 – volume: 278 start-page: 174 year: 2015 ident: B10 article-title: Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2014.11.003 – volume: 3 start-page: S68 year: 1997 ident: B15 article-title: Lack of correlation of Theiler's virus binding to cells with infection publication-title: J Neurovirol – volume: 76 start-page: 12834 year: 2002 ident: B18 article-title: Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity publication-title: J Virol doi: 10.1128/JVI.76.24.12834-12844.2002 – volume: 3 start-page: 579 year: 2008 ident: B16 article-title: Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection publication-title: Future Virol doi: 10.2217/17460794.3.6.579 – volume: 108 start-page: 233 year: 2002 ident: B48 article-title: Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin publication-title: Cell doi: 10.1016/S0092-8674(01)00638-9 – volume: 292 start-page: 85 year: 2014 ident: B9 article-title: Distinct kinetics of viral replication, T cell infiltration, and fibrosis in three phases of myocarditis following Theiler's virus infection publication-title: Cell Immunol doi: 10.1016/j.cellimm.2014.10.004 – year: 2012 ident: B46 article-title: Volcano plots in analyzing differential expressions with mRNA microarrays publication-title: J Bioinform Comput Biol doi: 10.1142/S0219720012310038 – start-page: 517 volume-title: Persistent Viral Infections. year: 1999 ident: B3 article-title: Theiler's murine encephalomyelitis virus – volume: 7 start-page: 444 year: 2014 ident: B33 article-title: Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis publication-title: Circ Cardiovasc Genet doi: 10.1161/CIRCGENETICS.114.000505 – volume: 28 start-page: 230 year: 2006 ident: B62 article-title: Multiple sclerosis as a vascular disease publication-title: Neurol Res doi: 10.1179/016164106X98080 – volume: 135 start-page: 1408 year: 1985 ident: B17 article-title: Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity publication-title: J Immunol doi: 10.4049/jimmunol.135.2.1408 – volume: 8 start-page: 177 year: 2017 ident: B69 article-title: Lymphatic system and gut microbiota affect immunopathology of neuroinflammatory diseases, including multiple sclerosis, neuromyelitis optica and Alzheimer's disease publication-title: Clin Exp Neuroimmunol doi: 10.1111/cen3.12405 – start-page: 61 volume-title: Viral Infections of the Nervous System year: 1998 ident: B56 article-title: Immune responses – volume: 89 start-page: 9896 year: 2015 ident: B68 article-title: Brain invasion by mouse hepatitis virus depends on impairment of tight junctions and beta interferon production in brain microvascular endothelial cells publication-title: J Virol doi: 10.1128/JVI.01501-15 – volume: 56 start-page: 1302 year: 1997 ident: B13 article-title: Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-199712000-00005 – volume: 190 start-page: 80 year: 2007 ident: B21 article-title: TGF-β1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2007.07.026 – volume: 15 start-page: 180 year: 2013 ident: B32 article-title: Acute viral myocarditis: current concepts in diagnosis and treatment publication-title: ISR Med Assoc J – volume: 523 start-page: 337 year: 2015 ident: B58 article-title: Structural and functional features of central nervous system lymphatic vessels publication-title: Nature doi: 10.1038/nature14432 – volume: 104 start-page: 1076 year: 2001 ident: B29 article-title: Advances in the understanding of myocarditis publication-title: Circulation doi: 10.1161/hc3401.095198 |
| SSID | ssj0000493335 |
| Score | 2.279758 |
| Snippet | Theiler's murine encephalomyelitis virus (TMEV) induces different diseases in the central nervous system (CNS) and heart, depending on the mouse strains and... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 2870 |
| SubjectTerms | adhesion molecules animal models Animals blood-brain barrier Cardiovirus Infections - immunology Cardiovirus Infections - virology Cell Line Central Nervous System - immunology Central Nervous System - metabolism computational analysis Cytokines - genetics Cytokines - immunology Demyelinating Autoimmune Diseases, CNS - immunology Demyelinating Autoimmune Diseases, CNS - virology Disease Models, Animal Gene Expression Profiling Gene Expression Regulation - immunology GLYCAM1 Host-Pathogen Interactions - genetics Host-Pathogen Interactions - immunology Humans Immunology Lymphatic Vessels - immunology Lymphatic Vessels - metabolism LYVE1 Mice Mice, Inbred Strains - immunology Myocarditis - immunology Myocarditis - virology Myocardium - immunology Myocardium - metabolism Oligonucleotide Array Sequence Analysis Principal Component Analysis Theilovirus - immunology |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fi9QwEA5yIPgiev6qehJBEB_iXpsmTXzzFo9V9B5OT-4tpMmEq3qt7HaR_e9vkuwtuyL64ksf2rQN-WYy3zCTGUJetKBL9NE046A9qz04ZptWMYfGt7TgygApQfZEzs7qD-fifKvVV8wJy-WB88JN0LxwCEpq56EWvLUllKgTdWNFY3kLcfdFm7flTH3LvJdzLnJcEr0wPQnd5eUypnKp14cxuLdjh1K5_j9xzN9TJbdsz_EdcntNGunbPNm75Ab0--RmbiO5ukd-Idao3POXC_q1my8X7FPqvwGevo-nP4bYdTgNpV1PkfDR6clnantPZyjm4xt6Gos60SHQdDCTpZb0oXN0uhqH78hC09iPK8Q9lnelpzmtFhb3ydnxuy_TGVs3VGBOVGpk0GjhvUUWpxXwIIRrpNa-9g63GtFC40p0iAEf4qWCIJ2SUmkIlpfBhsAfkL1-6OERoZWVwSur26ZFBy4IhEe3-FFRO0TeuYJMrpfXuHW18dj04odBryMCYhIgJgJiEiAFebV542eutPGXsUcRsc24WCM73UDJMWvJMf-SnII8v8bboE7FQIntYVguTFUib62R3FQFeZjx3_wKXSwkxUIVpNmRjJ257D7pu4tUt1vGmKrUj__H5J-QW3E5YmJNefiU7I3zJRwgPRrbZ0kTrgAeDBHA priority: 102 providerName: Directory of Open Access Journals |
| Title | Theiler's Virus-Mediated Immunopathology in the CNS and Heart: Roles of Organ-Specific Cytokine and Lymphatic Responses |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30619258 https://www.proquest.com/docview/2165042242 https://pubmed.ncbi.nlm.nih.gov/PMC6295469 https://doaj.org/article/5213ef869cde453ba1e176347a57a3be |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagCIkL4t0UqIyEhDikreM4iZEQghVlQbSHwqK9RX6MIbRNIMkK9t8zdtKFRStOXHyI7cTy5_F8E49nCHmsQTK00WTMQdo4tWBilesiNqh8mQLDHAQH2eNsOkvfzcX89_XocQK7jaadzyc1a8_2fn5fvkCBf-4tTtS3-646P194L61i78Cf210mV1Av5T6fwdFI9r8OXJhzLoazyo0d13RTCOG_iXf-7T75hz46vEGuj0SSvhyQv0kuQX2LXB1SSy5vkx-IPwp8-6Sjn6p20cVHIScHWPrW3whpfCbi0JRWNUUSSCfHH6iqLZ3i0u-f0RMf6Ik2jobLmnFIU-8qQyfLvjlFZhravl_iWvAhX-nJ4GoL3R0yO3z9cTKNxyQLsRFJ0ceQS2GtQmYnC-BOCJNnUtrUGtx-hIbcMDSSASuxSMBlpsiyQoJTnDnlHL9Ltuqmhm1CE5U5Wyipc41GnRPSWKnxpSI1uBqMicj-xfSWZoxA7hNhnJVoiXhAygBI6QEpAyARebrq8W2IvvGPtq88Yqt2Pm52eNC0n8tRDEskKxxckeHQIBVcKwYMd9g0VyJXXENEHl3gXaKc-cMTVUOz6MqEIZdNkfAkEbk34L_6FJpdSJRFEZF8bWWsjWW9pq6-hFjemT9nzeTO_xj8fXLNT4d3tmEHD8hW3y7gIVKmXu-GXw1Yvpmz3SAVvwArbRvL |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Theiler%27s+Virus-Mediated+Immunopathology+in+the+CNS+and+Heart%3A+Roles+of+Organ-Specific+Cytokine+and+Lymphatic+Responses&rft.jtitle=Frontiers+in+immunology&rft.au=Seiichi+Omura&rft.au=Seiichi+Omura&rft.au=Eiichiro+Kawai&rft.au=Fumitaka+Sato&rft.date=2018-12-10&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=9&rft_id=info:doi/10.3389%2Ffimmu.2018.02870&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_5213ef869cde453ba1e176347a57a3be |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |